Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy when a stem cell transplant is suitable
Technology appraisal guidance
Reference number: TA1048
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.